Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Pukhalskaya ( Moscow, Russian Federation), V. Shmarin ( Moscow, Russian Federation), S. Semykin ( Moscow, Russian Federation), L. Avakian ( Moscow, Russian Federation), N. Kashirskaya ( Moscow, Russian Federation), G. Shmarina ( Moscow, Russian Federation), V. Alioshkin ( Moscow, Russian Federation). Changes in local and systemic inflammatory markers in cystic fibrosis patients chronically infected with Burkholderia cepacia complex. 689

Member's Comments

No comment yet.

Related content which might interest you: Burkholderia cepacia infection in adult cystic fibrosis patients: Its impact on lung function and survival Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Burkholderia cepacia complex infection in Czech patients with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 503s Year: 2003 Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients Source: Eur Respir J 2004; 23: 851-856 Year: 2004 Dysregulation of systemic and local immune response in cystic fibrosis patients with chronic P. aeruginosa infection Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 Treatment of Burholderia cepacia infection in patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 539s Year: 2001 Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa Source: Eur Respir J 2003; 22: 503-506 Year: 2003 Survival outcomes following lung transplantation for cystic fibrosis patients infected with Burkholderia cenocepacia Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017 Year: 2017 Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa Source: Eur Respir J, 50 (1) 1601569; 10.1183/13993003.01569-2016 Year: 2017 Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis Source: Virtual Congress 2021 – Back to infection basics Year: 2021 TNF and LTA gene polymorphisms in cystic fibrosis patients with Burkholderia cepacia complex (Bcc) Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021 Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2007; 30: 286-292 Year: 2007 Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients Source: Eur Respir J 2001; 17: 36-38 Year: 2001 Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients Source: Eur Respir J 2008; 31: 822-829 Year: 2008 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 Systemic quorum sensing signal molecules are biomarkers for current and future P. aeruginosa infection in cystic fibrosis patients: A longitudinal study Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Sputum and plasma neutrophil elastase in stable adult patients with cystic fibrosis in relation to chronic Pseudomonas colonization. Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Polymorphisms of the IL-10 gene and pseudomonas aeruginosa infection in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006